GlycoMimetics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 1,266,737 N/A N/A
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 1,266,737 N/A N/A
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 1,266,737 $2.6 $3,293,516
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 932,612 N/A N/A
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 932,612 $2.75 $2,564,683
Purchase
JUNIUS DANIEL M director
 Common Stock 20,000 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Employee Stock Option (right to buy) 106,983 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 106,983 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Employee Stock Option (right to buy) 106,984 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 106,984 N/A N/A
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 1,668,746 N/A N/A
Purchase
BVF PARTNERS L P/IL 10 percent owner
 Common Stock, $0.001 par value 1,668,746 $3.18 $5,309,950
Purchase
JUNIUS DANIEL M director
 Common Stock 10,000 N/A N/A
Option
KING RACHEL K. director, officer: President, CEO
 Employee Stock Option (right to buy) 166,759 N/A N/A
Option
KING RACHEL K. director, officer: President, CEO
 Common Stock 166,759 N/A N/A
Sale
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 3,527 N/A N/A
Sale
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 7,273 N/A N/A
Sale
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 14,200 N/A N/A
Option
HAHN BRIAN M. officer: SVP Finance, CFO
 Employee Stock Option (right to buy) 5,260 N/A N/A
Sale
HAHN BRIAN M. officer: SVP Finance, CFO
 Common Stock 19,345 N/A N/A
Option
HAHN BRIAN M. officer: SVP Finance, CFO
 Common Stock 5,260 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Warrant to Purchase Common Stock (right to buy) 895 N/A N/A
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 1,491 N/A N/A
Sale
NEW ENTERPRISE ASSOCIATES 10 L P 10 percent owner
 Common Stock 9,539 $17.81 $169,890
Sale
BARRIS PETER J 10 percent owner
 Common Stock 9,539 $17.81 $169,890
Sale
BARRETT M JAMES director, 10 percent owner
 Common Stock 9,539 $17.81 $169,890
Sale
SANDELL SCOTT D 10 percent owner
 Common Stock 9,539 N/A N/A
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 2,000 $15.01 $30,020
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 2,000 $13 $26,000
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 2,000 $15.57 $31,140
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 2,000 $12.14 $24,280
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Employee Stock Option (right to buy) 8,928 $1.12 $9,999
Option
MAGNANI JOHN L. officer: SVP of Research, CSO
 Common Stock 8,928 $1.12 $9,999
Purchase
JUNIUS DANIEL M director
 Common Stock 5,000 $6.01 $30,050
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 4,000 $7.01 $28,020
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 2,000 $8 $16,000
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 6,796 $6.68 $45,397
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 10,136 $7.01 $71,053
Sale
THACKRAY HELEN M. officer: SVP Clinical Developme..
 Common Stock 5,068 $7.4 $37,503
Option
BALDWIN JOHN J. director
 Stock Option (right to buy) 605 $1.12 $678
Option
BALDWIN JOHN J. director
 Common Stock 605 $1.12 $678
Purchase
GOLDBERG MARK ALAN director
 Common Stock 10,397 $4.77 $49,635
Option
TOP FRANKLIN H JR director
 Stock Option (right to buy) 605 $1.12 $678
Option
TOP FRANKLIN H JR director
 Common Stock 11,689 $1.12 $13,092
Sale
BARRETT M JAMES director, 10 percent owner
 Common Stock 452 $6.91 $3,123
Sale
BARRIS PETER J 10 percent owner
 Common Stock 452 $6.91 $3,123
Sale
NEW ENTERPRISE ASSOCIATES 10 L P 10 percent owner
 Common Stock 452 $6.91 $3,123
Sale
SANDELL SCOTT D 10 percent owner
 Common Stock 452 $6.91 $3,123
Option
HAHN BRIAN M. officer: SVP Finance, CFO
 Common Stock 5,000 $1.12 $5,600
Option
HAHN BRIAN M. officer: SVP Finance, CFO
 Employee Stock Option (right to buy) 5,000 $1.12 $5,600

Showing 50 to 100 of 117 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: